Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Mesothelioma, Malignant × Radiotherapy, Conformal × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 9 Gliosarcoma 7 Prostatic Neoplasms 6 Glioblastoma 6 Lung Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 4 Brain Neoplasms 4 Sarcoma 3 Breast Neoplasms 3 Malignant mesenchymal tumor 2 Liposarcoma 2 Leiomyosarcoma 2 Histiocytoma, Malignant Fibrous 2 Hemangiosarcoma 2 Head and Neck Neoplasms 2 Fibrosarcoma 2 Central Nervous System Neoplasms 2 Astrocytoma 2 Adenocarcinoma, Bronchiolo-Alveolar 2 Adenocarcinoma of Lung 2 Vulvar Neoplasms 1 Vomiting 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Stomach Neoplasms 1 Stage II Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 1 Sarcoma, Synovial 1 Sarcoma, Alveolar Soft Part 1 Rhabdoid Tumor 1 Radiodermatitis 1

Interventions

Pemetrexed 14 Cisplatin 13 pembrolizumab 4 Platinum 4 1,2-diaminocyclohexaneplatinum II citrate 4 Radiotherapy 3 Gemcitabine 3 Carboplatin 3 cediranib 2 amatuximab 2 Radiotherapy, Intensity-Modulated 2 Radiation 2 Drug Therapy 2 Cyclophosphamide 2 tumor necrosis factor-alpha, CNGRC fusion protein, human 1 tremelimumab 1 sodium thiosulfate 1 sargramostim 1 nintedanib 1 napabucasin 1 methoxyamine 1 liposomal doxorubicin 1 incomplete Freund's adjuvant 1 fresolimumab 1 durvalumab 1 defactinib 1 cixutumumab 1 bintrafusp alfa protein, human 1 bemcentinib 1 belinostat 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡